FDA Inspection 1191049 — Liptis Pharmaceuticals USA Inc.
The FDA completed an inspection of Liptis Pharmaceuticals USA Inc. on November 2, 2022 in Spring Valley, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 2, 2022
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Spring Valley, NY (United States)